# Federal Register #2026-21258

DEA revokes physician’s controlled-substance registration and denies related applications

**Posted:** October 19, 2026
**Identifier:** 2026-21258

The Drug Enforcement Administration issued an enforcement decision concerning physician Muhamad Aly Rifai in Easton, Pennsylvania.
- **Government agency:** U.S. Department of Justice, Drug Enforcement Administration (DEA); no sub-agency or office is specified.
- **Action:** Revoked Dr. Rifai’s DEA controlled-substance registration and denied pending applications to renew or modify it, as well as applications for additional registration in Pennsylvania.
- **Basis:** The decision found that controlled substances were prescribed outside the usual course of professional practice and without a legitimate medical purpose, and that patient medical records had been falsified.
- **Procurement status:** This is an enforcement notice, not a procurement opportunity or contract award. No OEMs, vendors, products, quantities, or services are identified.

### Description

The Drug Enforcement Administration issued a decision revoking Muhamad Aly Rifai, M.D.’s DEA Certificate of Registration No. BR7552272 in Easton, Pennsylvania. The decision finds that his prescribing of controlled substances was outside the usual course of professional practice and not for a legitimate medical purpose, and that patient medical records were falsified. It also denies pending applications to renew or modify the registration and other pending applications for additional registration in Pennsylvania. The order is effective November 18, 2026.

[View original listing](https://www.federalregister.gov/documents/2026/10/19/2026-21258/muhamad-aly-rifai-md-decision-and-order)